These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23419719)

  • 21. The SETD8/PR-Set7 Methyltransferase Functions as a Barrier to Prevent Senescence-Associated Metabolic Remodeling.
    Tanaka H; Takebayashi SI; Sakamoto A; Igata T; Nakatsu Y; Saitoh N; Hino S; Nakao M
    Cell Rep; 2017 Feb; 18(9):2148-2161. PubMed ID: 28249161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone methyltransferase KMT5A gene modulates oncogenesis and lipid metabolism of papillary thyroid cancer in vitro.
    Liao T; Wang YJ; Hu JQ; Wang Y; Han LT; Ma B; Shi RL; Qu N; Wei WJ; Guan Q; Xiang J; Chen JY; Sun GH; Li DS; Mu XM; Ji QH
    Oncol Rep; 2018 May; 39(5):2185-2192. PubMed ID: 29512765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Product specificity and mechanism of protein lysine methyltransferases: insights from the histone lysine methyltransferase SET8.
    Zhang X; Bruice TC
    Biochemistry; 2008 Jun; 47(25):6671-7. PubMed ID: 18512960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural and functional analysis of SET8, a histone H4 Lys-20 methyltransferase.
    Couture JF; Collazo E; Brunzelle JS; Trievel RC
    Genes Dev; 2005 Jun; 19(12):1455-65. PubMed ID: 15933070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of the methylation of Numb by the SET8 protein lysine methyltransferase.
    Weirich S; Kusevic D; Kudithipudi S; Jeltsch A
    Sci Rep; 2015 Sep; 5():13813. PubMed ID: 26391684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SET8 plays a role in controlling G1/S transition by blocking lysine acetylation in histone through binding to H4 N-terminal tail.
    Yin Y; Yu VC; Zhu G; Chang DC
    Cell Cycle; 2008 May; 7(10):1423-32. PubMed ID: 18418072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new regulator of the cell cycle: the PR-Set7 histone methyltransferase.
    Wu S; Rice JC
    Cell Cycle; 2011 Jan; 10(1):68-72. PubMed ID: 21200139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural basis of nucleosomal H4K20 methylation by methyltransferase SET8.
    Shi L; Huang L; Long H; Song A; Zhou Z
    FASEB J; 2022 Jun; 36(6):e22338. PubMed ID: 35532550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic methylation of Numb by Set8 regulates its binding to p53 and apoptosis.
    Dhami GK; Liu H; Galka M; Voss C; Wei R; Muranko K; Kaneko T; Cregan SP; Li L; Li SS
    Mol Cell; 2013 May; 50(4):565-76. PubMed ID: 23706821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small-molecule inhibitors of SETD8 with cellular activity.
    Blum G; Ibáñez G; Rao X; Shum D; Radu C; Djaballah H; Rice JC; Luo M
    ACS Chem Biol; 2014 Nov; 9(11):2471-8. PubMed ID: 25137013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The histone H4 lysine 20 monomethyl mark, set by PR-Set7 and stabilized by L(3)mbt, is necessary for proper interphase chromatin organization.
    Sakaguchi A; Joyce E; Aoki T; Schedl P; Steward R
    PLoS One; 2012; 7(9):e45321. PubMed ID: 23024815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of p53 function by SET8-mediated methylation at lysine 382.
    Shi X; Kachirskaia I; Yamaguchi H; West LE; Wen H; Wang EW; Dutta S; Appella E; Gozani O
    Mol Cell; 2007 Aug; 27(4):636-46. PubMed ID: 17707234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The SET8 H4K20 protein lysine methyltransferase has a long recognition sequence covering seven amino acid residues.
    Kudithipudi S; Dhayalan A; Kebede AF; Jeltsch A
    Biochimie; 2012 Nov; 94(11):2212-8. PubMed ID: 22583696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone lysine methyltransferase SET8 is a novel therapeutic target for cancer treatment.
    Yang C; Wang K; Zhou Y; Zhang SL
    Drug Discov Today; 2021 Oct; 26(10):2423-2430. PubMed ID: 34022460
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Crain AT; Butler MB; Hill CA; Huynh M; McGinty RK; Duronio RJ
    bioRxiv; 2024 Mar; ():. PubMed ID: 38559189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone Methyltransferase SET8 Epigenetically Reprograms Host Immune Responses to Assist Mycobacterial Survival.
    Singh V; Prakhar P; Rajmani RS; Mahadik K; Borbora SM; Balaji KN
    J Infect Dis; 2017 Aug; 216(4):477-488. PubMed ID: 28931237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SET8 induces epithelial‑mesenchymal transition and enhances prostate cancer cell metastasis by cooperating with ZEB1.
    Hou L; Li Q; Yu Y; Li M; Zhang D
    Mol Med Rep; 2016 Feb; 13(2):1681-8. PubMed ID: 26717907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SET8 expression is associated with overall survival in gastric cancer.
    Shi XL; Guo ZJ; Wang XL; Liu XL; Shi GF
    Genet Mol Res; 2015 Dec; 14(4):15609-15. PubMed ID: 26634528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. microRNA-7 suppresses the invasive potential of breast cancer cells and sensitizes cells to DNA damages by targeting histone methyltransferase SET8.
    Yu N; Huangyang P; Yang X; Han X; Yan R; Jia H; Shang Y; Sun L
    J Biol Chem; 2013 Jul; 288(27):19633-42. PubMed ID: 23720754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ubiquitin-specific protease USP17 prevents cellular senescence by stabilizing the methyltransferase SET8 and transcriptionally repressing
    Fukuura K; Inoue Y; Miyajima C; Watanabe S; Tokugawa M; Morishita D; Ohoka N; Komada M; Hayashi H
    J Biol Chem; 2019 Nov; 294(44):16429-16439. PubMed ID: 31533987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.